Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Merck & Co., Inc. | 31,809.89 | reported | 25 May 2018 | tx 17+49,986.17−2,462 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 3,851 | reported | 08 May 2026 | tx 21+38,875 |
| REGENERON PHARMACEUTICALS, INC. | 1,962 | reported | 02 Jan 2026 | tx 10+9,995 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 May 2026 | GRANT_AWARD | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 1,438 | 177.62 USD | |
| 02 Jan 2026 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 155 | 0.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1,962 | 0.00 USD | deriv |
| 21 May 2025 | GRANT_AWARD | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 946 | 134.98 USD | |
| 21 May 2025 | GRANT_AWARD | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 2,076 | 134.98 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 166 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1,958 | 0.00 USD | deriv |
| 13 May 2024 | GRANT_AWARD | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 559 | 228.41 USD | |
| 13 May 2024 | GRANT_AWARD | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 1,311 | 228.41 USD | deriv |
| 02 Jan 2024 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 135 | 0.00 USD | |
| 02 Jan 2024 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1,607 | 0.00 USD | deriv |
| 15 May 2023 | GRANT_AWARD | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 664 | 0.00 USD | |
| 15 May 2023 | GRANT_AWARD | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 1,669 | 192.36 USD | deriv |
| 03 Jan 2023 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 40 | 0.00 USD | |
| 03 Jan 2023 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 477 | 0.00 USD | deriv |
| 03 Jan 2023 | GRANT_AWARD | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 244 | 0.00 USD | |
| 03 Jan 2023 | GRANT_AWARD | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 592 | 218.40 USD | deriv |
| 03 Oct 2022 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 279 | 0.00 USD | |
| 03 Oct 2022 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 3,216 | 0.00 USD | deriv |
| 25 May 2018 | GRANT_AWARD | Merck & Co., Inc. | 3,130.82 | 59.09 USD | deriv |
| 14 May 2018 | GRANT_AWARD | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 653 | 0.00 USD | |
| 14 May 2018 | GRANT_AWARD | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 2,004 | 0.00 USD | |
| 26 May 2017 | GRANT_AWARD | Merck & Co., Inc. | 2,618.61 | 64.92 USD | deriv |
| 12 May 2017 | GRANT_AWARD | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 2,436 | 0.00 USD | |
| 12 May 2017 | GRANT_AWARD | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 793 | 0.00 USD |